Bibliography
- Global alliance for TB drug development. 2013. Available from: http://www.tballiance.org/why/mdr-xdr.php [Cited 25 June 2014]
- Falzon D, van Gemert W, Glaziou P, et al. Management of drug-resistant tuberculosis: Policy Guidelines. National Department of Health, Republic of South Africa; 2013
- WHO. Global tuberculosis report 2013. World Health Organization, Geneva Switzerland; Available from: http://wwwwhoint/tb/publications/global_report/en/2013
- Weyer K, Lancaster J, Brand J, et al. Survey Of tuberculosis drug resistance in South Africa 2001 - 2002. Medical Research Council, Pretoria; 2004
- Pooran A, Pieterson E, Davids M, et al. What is the cost of diagnosis and management of drug resistant tuberculosis in South Africa? PLoS One 2013;8(1):e54587
- O’Donnell MR, Daftary A, Wolf A, et al. Adherence in the Treatment of Patients With Extensively Drug-Resistant Tuberculosis and HIV in South Africa: A Prospective Cohort Study. J Acquir Immune Defic Syndr 2014;67:22-9
- Farley JE, Ram M, Pan W, et al. Outcomes of multi-drug resistant tuberculosis (MDR-TB) among a cohort of South African patients with high HIV prevalence. PLoS One 2011;6(7):e20436
- O’Donnell MR, Padayatchi N, Kvasnovsky C, et al. Treatment outcomes for extensively drug-resistant tuberculosis and HIV co-infection. Emerg Infect Dis 2013;19(3):416-24
- Brust JC, Lygizos M, Chaiyachati K, et al. Culture conversion among HIV co-infected multidrug-resistant tuberculosis patients in Tugela Ferry, South Africa. PLoS One 2011;6(1):e15841
- Padayatchi N. Outcomes of MDR-TB: new regimens, new drugs and more... FIDDSA. Drakensberg, South Africa; 2013. Available from: http://www.fidssa.co.za/B_Fidssa13Cong_Pres.asp
- Van Deun A, Maug AK, Salim MA, et al. Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis. Am J Respir Crit Care Med 2010;182(5):684-92
- Loveday M, Padayatchi N, Voce A, et al. The treatment journey of a patient with multidrug-resistant tuberculosis in South Africa: is it patient-centred? Int J Tuberc Lung Dis 2013;17(10 Suppl 1):56-9
- Ebonwu JI, Tint KS, Ihekweazu C. Low treatment initiation rates among multidrug-resistant tuberculosis patients in Gauteng, South Africa, 2011. Int J Tuberc Lung Dis 2013;17(8):1043-8
- Narasimooloo R, Ross A. Delay in commencing treatment for MDR TB at a specialised TB treatment centre in KwaZulu-Natal. S Afr Med J 2012;102(6 Pt 2):360-2
- Pietersen E, Ignatius E, Streicher EM, et al. Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: a cohort study. Lancet 2014;383(9924):1230-9